Evaluating Social Media Networks in Medicines Safety Surveillance: Two Case Studies

被引:37
|
作者
Coloma, Preciosa M. [1 ]
Becker, Benedikt [1 ]
Sturkenboom, Miriam C. J. M. [1 ]
van Mulligen, Erik M. [1 ]
Kors, Jan A. [1 ]
机构
[1] Erasmus MC, Dept Med Informat, NL-3000 CA Rotterdam, Netherlands
关键词
MYOCARDIAL-INFARCTION; ROSIGLITAZONE; VACCINE; FAILURE; RISK;
D O I
10.1007/s40264-015-0333-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
There is growing interest in whether social media can capture patient-generated information relevant for medicines safety surveillance that cannot be found in traditional sources. The aim of this study was to evaluate the potential contribution of mining social media networks for medicines safety surveillance using the following associations as case studies: (1) rosiglitazone and cardiovascular events (i.e. stroke and myocardial infarction); and (2) human papilloma virus (HPV) vaccine and infertility. We collected publicly accessible, English-language posts on Facebook, Google+, and Twitter until September 2014. Data were queried for co-occurrence of keywords related to the drug/vaccine and event of interest within a post. Messages were analysed with respect to geographical distribution, context, linking to other web content, and author's assertion regarding the supposed association. A total of 2537 posts related to rosiglitazone/cardiovascular events and 2236 posts related to HPV vaccine/infertility were retrieved, with the majority of posts representing data from Twitter (98 and 85 %, respectively) and originating from users in the US. Approximately 21 % of rosiglitazone-related posts and 84 % of HPV vaccine-related posts referenced other web pages, mostly news items, law firms' websites, or blogs. Assertion analysis predominantly showed affirmation of the association of rosiglitazone/cardiovascular events (72 %; n = 1821) and of HPV vaccine/infertility (79 %; n = 1758). Only ten posts described personal accounts of rosiglitazone/cardiovascular adverse event experiences, and nine posts described HPV vaccine problems related to infertility. Publicly available data from the considered social media networks were sparse and largely untrackable for the purpose of providing early clues of safety concerns regarding the prespecified case studies. Further research investigating other case studies and exploring other social media platforms are necessary to further characterise the usefulness of social media for safety surveillance.
引用
收藏
页码:921 / 930
页数:10
相关论文
共 50 条
  • [1] Evaluating Social Media Networks in Medicines Safety Surveillance: Two Case Studies
    Preciosa M. Coloma
    Benedikt Becker
    Miriam C. J. M. Sturkenboom
    Erik M. van Mulligen
    Jan A. Kors
    Drug Safety, 2015, 38 : 921 - 930
  • [2] What Can Social Media Networks Contribute To Medicines Safety Surveillance?
    Coloma, Preciosa M.
    Becker, Benedikt
    Sturkenboom, Miriam C. J. M.
    van Mulligen, Erik M.
    Kors, Jan A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 467 - 468
  • [3] Social Media: the Battleground for Public Opinion on Medicines Safety
    Hoegberg, A.
    DRUG SAFETY, 2018, 41 (11) : 1163 - 1163
  • [5] Using Social Network Analysis to Visualize the Social-Media Networks of Community Groups: Two Case Studies from Sydney
    Williamson, Wayne
    Ruming, Kristian
    JOURNAL OF URBAN TECHNOLOGY, 2016, 23 (03) : 69 - 89
  • [6] Big Data and social media: surveillance of networks as management tool
    Klein, Gisiela Hasse
    Neto, Pedro Guidi
    Tezza, Rafael
    SAUDE E SOCIEDADE, 2017, 26 (01): : 208 - 217
  • [7] Narratives of Safety on Social Media: The Case of #mysafetyselfie
    Farhadi, Beyhan
    PROFESSIONAL GEOGRAPHER, 2018, 70 (01): : 140 - 149
  • [8] Utility of Social Media Surveillance for Drug Safety and Signal Detection Purposes
    Dreyfus, Brian
    Dasgupta, Jaidev
    Gomez-Caminero, Andres
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 282 - 282
  • [9] Social Media Listening for Routine Post-Marketing Safety Surveillance
    Powell, Gregory E.
    Seifert, Harry A.
    Reblin, Tjark
    Burstein, Phil J.
    Blowers, James
    Menius, J. Alan
    Painter, Jeffery L.
    Thomas, Michele
    Pierce, Carrie E.
    Rodriguez, Harold W.
    Brownstein, John S.
    Freifeld, Clark C.
    Bell, Heidi G.
    Dasgupta, Nabarun
    DRUG SAFETY, 2016, 39 (05) : 443 - 454
  • [10] Social Media Listening for Routine Post-Marketing Safety Surveillance
    Gregory E. Powell
    Harry A. Seifert
    Tjark Reblin
    Phil J. Burstein
    James Blowers
    J. Alan Menius
    Jeffery L. Painter
    Michele Thomas
    Carrie E. Pierce
    Harold W. Rodriguez
    John S. Brownstein
    Clark C. Freifeld
    Heidi G. Bell
    Nabarun Dasgupta
    Drug Safety, 2016, 39 : 443 - 454